Myths and Facts About Glimepiride

Shunmugavelu, M and Shah, T and kumar, G V and Sudagani, J and Arivazhahan, A and Khader, J and Mohan, V (2019) Myths and Facts About Glimepiride. Journal of the Association of Physicians, 67 . p. 24.



Glimepiride is either used as monotherapy or in combination with metformin or insulin for effective control of hyperglycemia in people with type 2 diabetes mellitus. In spite of its effective glucose-lowering potential, similar to other sulfonylureas, glimepiride has been associated with several myths like cardiovascular risk, hypoglycemic effects, weight gain, beta-cell failure, risk in special populations of diabetic patients, and effects of metabolites. Here, we will discuss the myths and facts associated with glimepiride and its safety and concern issues

Item Type:Article
Official URL/DOI:
Uncontrolled Keywords:Type 2 Diabetes
Divisions:Department of Diabetology
ID Code:1177
Deposited By:surendar radha
Deposited On:05 Feb 2020 14:18
Last Modified:05 Feb 2020 14:18

Repository Staff Only: item control page